Evaluation of Dosimetric Parameters and Disease Response After 125Iodine Transperineal Brachytherapy for Low- and Intermediate-Risk Prostate CancerWilliam Morris, Ryan Woods, Tom Pickles et al.|International Journal of Radiation Oncology*Biology*Physics|2008Cited by 64
143 The five-year relapse-free and overall survival following permanent 125 iodine prostate brachytherapy j. morrisMira Keyes, William Kwa, Michael McKenzie et al.|Radiotherapy and Oncology|2006Cited by 3
ASCENDE-RT∗, a randomized trial of brachytherapy: First report of the pilot with a median 52m followup: Cancer outcomes, treatment-related toxicity and patient-reported QOLWilliam Morris, Ingrid Spadinger, William Kwa et al.|Brachytherapy|2008Cited by 1